https://www.selleckchem.com/pr....oducts/Fedratinib-SA
We directly applied our assay to a clinical analysis of circulating TEVs from 50 µL of serum, revealing potential applications of nucleolin+ TEVs for nasopharyngeal carcinoma cancer (NPC) diagnosis and PD-L1+ TEVs for therapeutic monitoring. Conclusion The platform was simple and easy to operate, and this approach should be useful for the highly sensitive and versatile quantification of TEV proteins in clinical samples.Hepatocellular carcinoma (HCC) is the third most frequent cause of cancer-related deaths globally
Like
Comment
Share
